JPS6028990A - Novel peptide - Google Patents
Novel peptideInfo
- Publication number
- JPS6028990A JPS6028990A JP58116616A JP11661683A JPS6028990A JP S6028990 A JPS6028990 A JP S6028990A JP 58116616 A JP58116616 A JP 58116616A JP 11661683 A JP11661683 A JP 11661683A JP S6028990 A JPS6028990 A JP S6028990A
- Authority
- JP
- Japan
- Prior art keywords
- observed
- substance
- cultured
- growth
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、下式(1)
(但し、上一式中l5ovalerylはインバレリル
基を表わし、Tyr及びVatはそれぞれチロシン及び
バリンの残有を示す。)で表わされる新規なペプチドに
関する。Detailed Description of the Invention The present invention provides a novel peptide represented by the following formula (1) (in the above formula, 15ovaleryl represents an invaleryl group, and Tyr and Vat represent residual tyrosine and valine, respectively). Regarding.
近年、安全性の高いしかも効力の強い医薬−農薬という
ものの要求が高まシ、生理活性を有するアミノ酸類化合
物、低分子ペプチド化合物にその可能性を見い出すべく
種々の研究がなされている。In recent years, there has been an increasing demand for highly safe and highly effective pharmaceuticals and agrochemicals, and various studies have been conducted to discover the potential of physiologically active amino acid compounds and low-molecular-weight peptide compounds.
本発明者らは、生体の制御機構におけるプロテアーゼの
重要な役割に注目し、プロテアーゼ抑制物質の探索を目
的として、広く微生物の培養物を検討していたところ、
ストレフ’)ミセス属に属する菌株が、培養物中に、プ
ロテアーゼの活性を強く阻害する作用を持った物質を生
成蓄積する事実を発見し、とれを単離、構造を決定した
。The present inventors focused on the important role of proteases in the control mechanism of living organisms, and conducted a wide range of studies on microbial cultures with the aim of searching for protease inhibitors.
We discovered that a strain belonging to the genus Stref') produces and accumulates a substance in culture that has the effect of strongly inhibiting protease activity, isolated it, and determined its structure.
本発明物質は、l5ovaleryl −Tyr −V
al−Arginalの構造を有し、動植物及び微生物
起源のプロテアーゼによる蛋白分解を強く阻害する作用
を有し、筋ジストロフィー、腎性高血圧症の治療薬とし
ての用途が期待される。The substance of the present invention is l5ovaleryl-Tyr-V
It has an al-Arginal structure and has the effect of strongly inhibiting proteolysis by proteases of animal, plant and microbial origin, and is expected to be used as a therapeutic agent for muscular dystrophy and renal hypertension.
キーウリ等の双子葉植物の種子の発芽、発根を少量で抑
制し、良薬としても用途が期待される。It suppresses the germination and rooting of seeds of dicotyledonous plants such as cucumber in small amounts, and is expected to be used as a good medicine.
本発明物質を産生ずる菌SAB −934株は、昭和5
.6年7月に和歌山県田辺市の土壌よシ分離された。S
AB −934株は、後述する性状を持ち、既知のスト
レプトミセス・ガルチェリイに類似するが、気菌糸の着
生状態、炭素源の利用性に若干の差が認められること及
び本発明物質の産生性で大きな相違があるため、発明者
らはこれを新種と認め、ストレットミセス・タナペエン
シス(Streptomycestanabensis
)と命名すると共に、本菌を工業技術院微生物工業技
術研究所に寄託した。(受託番号微工研寄菌第6938
号FEBMP −6938)〔ストレプトミセス・タナ
ペエンシス(SAB−934株)の菌学的特徴〕
1、形態
顕微鏡下でよく分岐した基中菌糸から僅かに波形の気菌
糸が多数伸長するのを認める。輪生枝は認められず、直
線型(Reetus )である。The bacterium SAB-934 strain that produces the substance of the present invention is
.. It was isolated from soil in Tanabe City, Wakayama Prefecture in July 2006. S
AB-934 strain has the properties described below and is similar to the known Streptomyces garcherii, but there are slight differences in the state of aerial mycelial attachment and availability of carbon sources, and the productivity of the substance of the present invention. The inventors recognized this as a new species and called it Streptomyces tanapeensis.
) and deposited this bacterium with the Institute of Microbial Technology, Agency of Industrial Science and Technology. (Accession number Microtechnical Research Institute Bacteria No. 6938
No. FEBMP-6938) [Mycological characteristics of Streptomyces tanapeensis (SAB-934 strain)] 1. Morphology Under a microscope, a large number of slightly wavy aerial hyphae were observed extending from well-branched basal hyphae. No whorled branches are observed, and the branch is straight (Reetus).
2、各培地における生育状態
以下の記載中、()内はコンテナー・コーポレーション
・オプ・アメリカ(Container Corpor
ationof America ) (D カラー・
ハーモニイ・マニュアル(Co1or harmony
manual )に基く色彩表示である。2. Growth status in each medium In the following descriptions, the numbers in parentheses are those of Container Corporation Op America.
ation of America) (D color/
Harmony Manual (Co1or harmony
This is a color display based on the manual.
■シュクロース・硝酸塩寒天培地(28℃培養)無色か
らりすい黄のかかった発育上に、白色(、)の気菌糸を
わずかに着生。裏面は無色〜黄灰色。溶解性色素の産生
は認められない。■Sucrose/nitrate agar medium (cultured at 28℃) A small amount of white (,) aerial mycelia grew on the colorless to pale yellow growth. The underside is colorless to yellow-gray. No production of soluble pigment is observed.
■グリセリン・アスパラギン寒天培地(28℃培養)赤
味をおびた灰色発育上に赤褐色(5ne)の気菌糸をわ
ずかに着生。裏面は赤灰色で、溶解性色素はうすい赤紫
を呈し、0.05N HCt 。■Glycerin/asparagine agar medium (cultured at 28°C) A small amount of reddish-brown (5ne) aerial mycelia grew on the reddish gray growth. The back surface is reddish-gray, and the soluble dye exhibits a pale reddish-purple color under 0.05N HCt.
NaOHによって変色しない。Does not change color due to NaOH.
■グルコース・アスパラギン寒天培地(28℃培養)無
色の発育上に灰白色(b)の気菌糸を着生するが極めて
貧弱。裏面は、無色。溶解性色素の産生は認められない
。■Glucose-asparagine agar medium (cultured at 28°C) Gray-white (b) aerial mycelium grows on the colorless growth, but it is extremely poor. The back side is colorless. No production of soluble pigment is observed.
■グルコース・ツアペック寒天培地(28℃培養)無色
の発育は貧弱とはいえないが、気菌糸の着生及び溶解性
色素の産生はともに認められない。■Glucose Czapek agar medium (cultured at 28°C) Colorless growth cannot be said to be poor, but neither aerial mycelial attachment nor production of soluble pigments is observed.
■スターチ寒天培地(28℃培養)
うすい灰色の発育上に白色(13ha)の気菌糸を着生
。裏面はうすい黄土色で、黄土色の溶解性色素の産生が
認められる。■Starch agar medium (cultured at 28°C) White (13 ha) aerial mycelium grew on the pale gray growth. The underside is pale ocher, and production of ocher soluble pigment is observed.
■栄養寒天培地(28℃培養)
発育は貧弱で無色。気菌糸の産生、溶解性色素の産生は
認められない。■Nutritional agar medium (cultured at 28℃) Growth is poor and colorless. Production of aerial mycelia and production of soluble pigments were not observed.
■普通寒天培地(28℃培養)
発育は貧弱で無色。気菌糸の着生、溶解性色素の産生は
認められない。■Normal agar medium (cultured at 28℃) Growth is poor and colorless. No attachment of aerial mycelia or production of soluble pigments was observed.
■ペプトン・グルコース寒天培地(28℃培養)無色の
発育は貧弱とはいえないが、気菌糸の着生、溶解性色素
の産生けともに認められない。■Peptone-glucose agar medium (cultured at 28°C) Colorless growth cannot be said to be poor, but neither aerial mycelial attachment nor production of soluble pigments were observed.
■チロシン寒天培地(28℃培養)
淡褐色の発育上に、灰白色(b)の気菌糸を着生。裏面
は赤味をおびた淡褐色。わずかに褐色の溶解性色素の産
生が認められる。■Tyrosine agar medium (cultured at 28°C) Gray-white (b) aerial mycelium grows on the light brown growth. The underside is light brown with a reddish tinge. Production of a slightly brown soluble pigment is observed.
■パレイシ田片培地(28℃培養)
発育は吸盤状のシワのあるよく発達した淡褐灰楓。気菌
糸の着生、溶解性色素の産生は認められない。なお8週
間後に灰白色(b)の気菌糸の着生が認められた。■Pareishi Tagata medium (cultured at 28℃) A well-developed light brown gray maple with sucker-shaped wrinkles. No attachment of aerial mycelia or production of soluble pigments was observed. After 8 weeks, the growth of gray-white (b) aerial mycelia was observed.
■エフ2フ片培地(28℃培養)
発育は吸盤状のシワのある淡褐灰色。気菌糸の着生、溶
解性色素の産生は認められない。■F2 Fragment medium (cultured at 28℃) Growth is light brownish gray with sucker-shaped wrinkles. No attachment of aerial mycelia or production of soluble pigments was observed.
■馬血清寒天培地(28℃培養)
発育は無色で貧弱。気菌糸の着生、溶解性色素の産生は
認められない。■Horse serum agar medium (cultured at 28℃) Growth is colorless and poor. No attachment of aerial mycelia or production of soluble pigments was observed.
■セルレース寒天培地(28℃培養) 2週間の観察中、生育は認められない。■Cellulase agar medium (28℃ culture) No growth was observed during 2 weeks of observation.
■イースト・麦芽寒天培地(28℃培養)褐灰色の発育
上に、白色(、)の気菌糸を着生。■Yeast/malt agar medium (cultured at 28℃) White (,) aerial mycelia are attached to the brownish-gray growth.
裏面は褐灰色。溶解性色素の産生は認められない。The back side is brownish gray. No production of soluble pigment is observed.
■オートミール寒天培地(28℃培養)無色から黄味の
かかった発育上に白色(、)の気菌糸をわずかに着生。■Oatmeal agar medium (cultured at 28°C) A slight white (,) aerial mycelium grows on the colorless to yellowish growth.
溶解性色素の産生は認められない。No production of soluble pigment is observed.
■ペプトン・イースト・鉄寒天培地(28℃培養)発育
は無色で貧弱、まれに黄味をおびた灰色(2ba)の気
菌糸を着生。裏面は無色で、溶解性色素の産生は認めら
れない。■Peptone yeast/iron agar medium (cultured at 28°C) Growth is colorless and poor, rarely with yellowish gray (2ba) aerial mycelium. The back side is colorless and no production of soluble pigment is observed.
O卵培地(28℃培養)
発育はきわめて貧弱で無色。気菌糸の着生、溶解性色素
の産生けともに認められない。O egg medium (cultured at 28°C) Growth is extremely poor and colorless. Neither aerial hyphae nor production of soluble pigments were observed.
■牛乳(Litmus m1lk )培地(28℃培養
)白色系の菌体が沈澱部で生育し、リドマス試薬がわず
かに赤変していることが認められるもののペプトン化、
凝固はともに認めがたい。■Milk (Litmus m1lk) medium (cultured at 28°C) White bacterial cells grow in the sediment, and the lidmus reagent is slightly reddish, but peptonization occurs.
Coagulation was difficult to detect in either case.
■ゼラチン穿刺培養(28℃培養)
わずかに生育が認められるものの、溶解性色素の産生及
びゼラチンの液化はともに認められない。■Gelatin puncture culture (28°C culture) Although slight growth is observed, neither production of soluble pigment nor liquefaction of gelatin is observed.
■ペプトン水(1,0%硝酸塩含有)
無から白色系の菌体が沈澱部に生育し、溶解性色素の産
生は認められない。硝酸還元反応は陽性である。■Peptone water (contains 1.0% nitrate) White to white bacterial cells grow in the sediment, and no production of soluble pigments is observed. Nitrate reduction reaction is positive.
3、生理的性質
(1)生育温度範囲
イースト・麦芽液体培地を用いて10〜45℃の範囲に
おいて試験の結果、最適温度は28℃付近である。また
生育した菌体容量の比較から、最適温度におけるものに
対して5チ以上生育する温度範囲は14〜37℃、30
%以上では20〜33℃であった。3. Physiological Properties (1) Growth Temperature Range As a result of tests using a yeast/malt liquid medium in the range of 10 to 45°C, the optimum temperature is around 28°C. Also, from a comparison of the capacity of grown bacteria, the temperature range for growing 5 or more cells is 14-37℃, 30℃ compared to that at the optimal temperature.
% or more, the temperature was 20 to 33°C.
(2)ゼラチンの液化(ゼラチン穿刺培養)液化能は認
められない。(2) Liquefaction of gelatin (gelatin puncture culture) No liquefaction ability was observed.
(3)スターチの加水分解(スターチ寒天培地)ルゴー
ル液染色において、プレート全体が赤味を呈することか
ら、アミロースの加水分解は人混にわたるがアミロペク
チンの加水分解能は低い。(3) Hydrolysis of starch (starch agar medium) In Lugol's solution staining, the entire plate appears reddish, indicating that the hydrolysis of amylose is widespread, but the ability to hydrolyze amylopectin is low.
(4)脱脂牛乳の凝固及びペプトン化(リドマスミルク
培地)
両者ともに認められ々い。(4) Coagulation and peptonization of skim milk (Lidomas milk medium) Both were not observed.
(5)メラニン様色素の形成
チロシン寒天培地でわずかに産生が認められるがペプト
ン・イースト・鉄寒天培地では認められない。ゼラチン
においても認められない。(5) Formation of melanin-like pigment Slight production is observed on tyrosine agar medium, but not on peptone yeast iron agar medium. It is also not observed in gelatin.
(6)炭素源の利用性(プリドハム・ゴツトリープグル
コース、ガラクトースを利用して生育するが、キシロー
ス、フルクトース、アラビノース、シュクロース、イノ
シトール、ラムノース、ラフィノース、マンニ)−ルを
利用しない。(6) Utilization of carbon sources (Pridham Gottlieb grows using glucose and galactose, but does not use xylose, fructose, arabinose, sucrose, inositol, rhamnose, raffinose, manniol).
以上の性状を要約すると、8AB−934株はストレプ
トミセス属に属し、気菌糸は単純分岐形で、直線型を永
し、胞子の表面は平滑でおる。種々のがって、本菌は非
クロモジェニック型の菌である。To summarize the above characteristics, strain 8AB-934 belongs to the genus Streptomyces, the aerial hyphae are simply branched and linear, and the spores have smooth surfaces. For various reasons, this bacterium is a non-chromogenic bacterium.
チロシン寒天培地にわずかのメラニン様色素の生成が認
められる。ゼラチンの液化、脱脂牛乳の凝固及び液化は
陰性で、硝酸塩の還元反応は全て陽性で、スターチの加
水分解能はやや強い。A slight amount of melanin-like pigment is observed on the tyrosine agar medium. Liquefaction of gelatin, coagulation and liquefaction of skim milk were negative, nitrate reduction reactions were all positive, and starch hydrolysis ability was somewhat strong.
これらの特徴的性状を有する既知菌種を検索したが、類
似した菌種を見出せなかった。比較的類似していると思
われるものにストレプトミセス・ガルチェリイ(Str
eptomyces galtieri )があるが、
こしt−パージエイズ・マニュアル・オブ・ディターミ
ナティブ・バクテリオロジ−(Bergcy’s Ma
nnualof Deterrninative Ba
cteriology ) 8版、及びワクスマン(W
aksman )のジ・アクチノミセテス(TheAc
tinomycete@) 2巻・215頁(1961
)に基いてSAB −934の性状と比較すると下記の
とおルである。Although we searched for known bacterial species with these characteristic properties, we were unable to find any similar bacterial species. One that seems to be relatively similar is Streptomyces garcherii (Str.
eptomyces galtieri), but
Bergcy's Manual of Determinative Bacteriology
nualof Deterrnative Ba
cteriology) 8th edition, and Waksman (W
The Actinomycetes (TheAc
tinomycete@) Volume 2, page 215 (1961
), the properties are compared with those of SAB-934 as follows.
以上の相違は明らかに種内変異の範ちゅうを超えるもの
である。The above differences clearly go beyond the scope of intraspecific variation.
本発明物質を製造する際に使用される培地は、液状でも
固状でもよいが、通常は液体培地による振盪培養または
通気攪拌培養が便利である。培地は本発明物質生産菌が
生育して培地中に本発明物質を蓄積するものであればど
のようなものでもよい。即ち、炭素源としては、例えば
グルコース、ラクトース、グリセリン、デンプン、シュ
クロース、デキストリン、精密、有機酸類などが、また
窒素源としては、例えばペグトン、カザミノ酸などの蛋
白加水分解物、肉エキス、酵母エキス、大豆粕、コーン
ステイブリカー、アミノ酸類、アンモニウム塩、硝酸塩
その他の各種有機あるいは無機窒素化合物が用いられる
。無機塩として各11 +7ン酸塩、硫酸マグネシウム
、塩化ナトリウムを添加してもよく、また茜の生育を促
進する目的でビタミン類、核酸関連化合物などを添加し
てもよい。The medium used in producing the substance of the present invention may be liquid or solid, but shaking culture or aerated agitation culture using a liquid medium is usually convenient. Any medium may be used as long as the microorganisms producing the substance of the present invention grow and the substance of the present invention is accumulated in the medium. That is, carbon sources include, for example, glucose, lactose, glycerin, starch, sucrose, dextrin, organic acids, etc., and nitrogen sources include, for example, protein hydrolysates such as pegtone and casamino acids, meat extracts, and yeast. Extracts, soybean meal, corn stable liquor, amino acids, ammonium salts, nitrates, and various other organic or inorganic nitrogen compounds are used. As inorganic salts, 11+7 phosphates, magnesium sulfate, and sodium chloride may be added, and vitamins, nucleic acid-related compounds, etc. may be added for the purpose of promoting the growth of madder.
なお、シリコン、ポリゾロ−レンゲリコール誘導体、大
豆油などの消泡剤を培地の添加が本発明物質の蓄積量を
増大させるのに効果的な場合もある。In some cases, addition of an antifoaming agent such as silicone, polyzorolene gellicol derivative, soybean oil, etc. to the medium may be effective in increasing the amount of the substance of the present invention accumulated.
培養にあたっては、いきなル本培養するよシは予め小規
模な前培養を行って得られる培養物を培地に接種するの
が望ましい。培養温度、培養期間、培養の液性などの条
件は、本発明物質の蓄積量が最大となるように適当に選
択、調節されるが、多くの場合、好気的条件下に25℃
〜35℃、3〜7日の培養でよく、また培地の液性紘p
H4〜7に保つのがよい。When culturing, it is preferable to inoculate the culture medium with the culture obtained by performing a small-scale preculture in advance, in case of main culture. Conditions such as culture temperature, culture period, culture liquid, etc. are appropriately selected and adjusted so as to maximize the accumulation of the substance of the present invention.
Cultivation at ~35°C for 3 to 7 days is sufficient;
It is best to keep it at H4-7.
このように培養することによシ、培養物中に本発明物質
が生成蓄積される。液体培地を用いて培養した場合は、
主としてその液状部分に目的物が蓄積されるので、培養
物を一旦濾過あるいは遠心分離して菌体を除去した後の
戸液あるいは上清液からこれを分離するのが好ましいが
、必要に応じ菌体を除°去−することなく培養液から直
接目的物を分離することもできる。培養物からの目的物
の分離、精製には、本発明物質の化学的特性に基づく種
々の手段が採択される。即ち、例えば硫酸アンモニウム
等の沈澱剤の添加による沈澱、n−ブタノールなどの水
と任意に混合せず、しかも、本発明物質を溶解しうる有
機溶媒による抽出、メタノール、エタノールなどの極性
の大きい溶媒への溶解、ヘキサンなどで処理することに
よる不純物の除去、セファデックス類によるダル濾過、
イオン交換樹脂、イオン交換セルロース、イオン交換セ
ファデックスなど各種イオン交換体によるイオン交換ク
ロマトグラフィー、活性炭、アルミナ、シリカゲル、ア
ンバーライトXAD−1,2,HP−20などの吸着剤
を用いる吸着クロマトグラフィーなどが有効に用いられ
、これらの手段を適当に組み合わせて使用することによ
シ、本発明物質は粉末状に単離される。但し、これら以
外の方法であっても、本発明物質の特性を有効に利用す
るものであれば適宜使用できる。By culturing in this manner, the substance of the present invention is produced and accumulated in the culture. When cultured using a liquid medium,
Since the target substance is mainly accumulated in the liquid part, it is preferable to separate it from the liquid or supernatant liquid after removing the bacterial cells by filtering or centrifuging the culture. It is also possible to separate the target substance directly from the culture medium without removing the body. Various means based on the chemical properties of the substance of the present invention may be employed to separate and purify the target product from the culture. That is, for example, precipitation by adding a precipitant such as ammonium sulfate, extraction with an organic solvent such as n-butanol that is not arbitrarily mixed with water and can dissolve the substance of the present invention, and highly polar solvent such as methanol or ethanol. Dissolution, removal of impurities by treatment with hexane, etc., dull filtration with Sephadex,
Ion exchange chromatography using various ion exchangers such as ion exchange resin, ion exchange cellulose, and ion exchange Sephadex, adsorption chromatography using adsorbents such as activated carbon, alumina, silica gel, Amberlite XAD-1, 2, and HP-20, etc. By using a suitable combination of these means, the substance of the present invention can be isolated in powder form. However, methods other than these can be used as appropriate as long as they effectively utilize the properties of the substance of the present invention.
1、 元素分析値
(C25H4oN605・4H20として)23分子量
:504.6(C25H4oN605として)3、 融
点:184℃−188℃(分解)4、比旋光度:〔α
発’−10,9°(C=o、 137 in H2O)
5、紫外線吸収スペクトル:278nmにチロシンに特
異的な吸収が認められる。1. Elemental analysis value (as C25H4oN605/4H20) 23 Molecular weight: 504.6 (as C25H4oN605) 3. Melting point: 184℃-188℃ (decomposition) 4. Specific optical rotation: [α
-10,9° (C=o, 137 in H2O)
5. Ultraviolet absorption spectrum: Absorption specific to tyrosine is observed at 278 nm.
6、FD−MS: rrv’Z 504 (M+)7、
赤外線吸収スペクトル
2950(CH)
1630 (amide l 、 guanidlni
um )1540(amiden)、1500(phe
nyl)8、核磁気共鳴スペクトル
0.80ppm (CHs、d、J=6.5Hz)0−
83 ppm (c!!3. d 、 J 〜6.5
Hz )0−90 ppm (C五、 d 、 J 〜
6.5 Hz )0−94 ppm (C5、d 、J
〜6−5 Hz )1、50 ppm (CH、m
)
1.70〜1.90ppm (5H,m)2.09pp
m (2H,m)
2.94ppm (2H,m)
3.15〜4.12ppm (3H,m)4、50〜4
.65 ppm (2H、m )4、96 ppm(0
,5H,d 、 J=4Hz ) 5.42ppm(0
,5H,d 、 J=3Hz )6.80ppm (I
H,d 、 J=7.3Hz )6.82ppm (I
H,d 、 J=7.3Hz )7、llppm (I
H,d、J=7.3Hz)7.13ppm (IH,d
、J=7.3Hz)9、各種溶媒に対する溶解性:
水、メタノール、エタノールに易溶、ブタノールニ可溶
、ベンゼン、エーテル、石油エーテル、クロロホルム、
四塩化炭素、ヘキサン、酢酸エチルには難溶である。6, FD-MS: rrv'Z 504 (M+)7,
Infrared absorption spectrum 2950 (CH) 1630 (amide l, guanidlni
um) 1540 (amiden), 1500 (phe
nyl) 8, nuclear magnetic resonance spectrum 0.80 ppm (CHs, d, J = 6.5 Hz) 0-
83 ppm (c!!3.d, J~6.5
Hz) 0-90 ppm (C5, d, J ~
6.5 Hz) 0-94 ppm (C5, d, J
~6-5 Hz) 1,50 ppm (CH, m
) 1.70-1.90ppm (5H, m) 2.09pp
m (2H, m) 2.94ppm (2H, m) 3.15~4.12ppm (3H, m) 4, 50~4
.. 65 ppm (2H, m)4, 96 ppm (0
,5H,d, J=4Hz) 5.42ppm(0
,5H,d, J=3Hz)6.80ppm (I
H, d, J=7.3Hz)6.82ppm (I
H, d, J=7.3Hz) 7, llppm (I
H, d, J = 7.3 Hz) 7.13 ppm (IH, d
, J=7.3Hz) 9. Solubility in various solvents: Easily soluble in water, methanol, ethanol, soluble in butanol, benzene, ether, petroleum ether, chloroform,
It is sparingly soluble in carbon tetrachloride, hexane, and ethyl acetate.
10、呈色反応:
坂口反応及びトレンズテストに陽性、ニンヒドリン及び
2,4−ジニトロフェニル・ヒドラジンには陰性である
。10. Color reaction: Positive for Sakaguchi reaction and Tollen's test, negative for ninhydrin and 2,4-dinitrophenyl hydrazine.
11、構成成分ニ アミノ酸分析によシ、チロシン、バリンを含む。11. Components D Amino acid analysis includes tyrosine, valine, and valine.
アミノ酸分析結果
Nモル モル比 アミノ酸数
グリシン 0.110 0.014 0システイy O
,1070,0140
パ リ ン 7.748 1.004 1イソ四イ7ン
0.239 0.031 0チ四シン 7.717
1.0 1
〔日立製作所アミノ酸分析計モデル835〕以上の物理
化学的分析結果を総合して、本発明物質の化学構造はl
5ovaleryl −(Tyr 、 Val )−A
rgininalと構造決定された。Amino acid analysis results N moles Molar ratio Number of amino acids Glycine 0.110 0.014 0 Cystay O
, 1070,0140 Palin 7.748 1.004 1 Iso-4-7 0.239 0.031 0-4-4 7.717
1.0 1 [Hitachi Amino Acid Analyzer Model 835] Comprehending the above physicochemical analysis results, the chemical structure of the substance of the present invention is l
5ovaleryl-(Tyr, Val)-A
The structure was determined to be rgininal.
アミノ酸配列:
本物質1〜を1−重炭酸ソーダo、IWLlに溶解し、
これをキモートリグシン0.051Vを加えて、40℃
、1時間反応させた。この反応液2oμtをと、り0.
25チダンシルクロライド2oμtを加え40℃、20
分間反応させた後、減圧乾固し、6礪定塩酸を加え、真
空下105℃、24時間加水分解した。加水分解物を減
圧乾固した後、50チピリジン溶液に溶解し、これをポ
リアミド薄層を用いて1.5%ギ酸水溶液及びベンゼン
−酢酸(9:1)で2次展開した。これを紫外線ランプ
下で照射したところ、裏面にマーカーとしてつけたDN
S −Valineと一致した。Amino acid sequence: This substance 1~ is dissolved in 1-sodium bicarbonate o, IWLl,
Add 0.051 V of chymotrigsin to this and hold at 40°C.
, and reacted for 1 hour. Take 2 μt of this reaction solution and add 0.0 μt.
Add 2 μt of 25 thidansyl chloride and heat at 40℃ for 20 minutes.
After reacting for a minute, the mixture was dried under reduced pressure, 6 volumes of constant hydrochloric acid was added, and the mixture was hydrolyzed under vacuum at 105°C for 24 hours. After drying the hydrolyzate under reduced pressure, it was dissolved in a 50-tipyridine solution, and this was secondarily developed using a polyamide thin layer with a 1.5% aqueous formic acid solution and benzene-acetic acid (9:1). When this was irradiated under an ultraviolet lamp, the DN attached as a marker on the back side
It matched with S-Valine.
以上の結果から、本発明物質の化学構造式は下記と決定
された。From the above results, the chemical structural formula of the substance of the present invention was determined to be as follows.
H
〔本発明物質の生理活性〕
■9本発明物質の酵素阻害活性
測定法
本発明物質と酵素溶液とを混合し、30℃で5分間プレ
インキュベイトしてから基質溶液を混合して反応を開始
させる。基質として0.5%カゼインを用い、その他に
5mM塩化カルシウム、10 mMシスティン及び50
mM)リス−塩酸緩衝液(pH7,5)を加え、30℃
で30分間反応させる。次いで反応液に6.5 % )
’)クロル酢酸を加えて反応を停止させ、酵素によシ
加水分解されたカゼインのトリクロル酢酸可溶画分中の
タン/?り量をローリ−・フォリン(Lowy −Fo
lin )法によシ測定し、対照液との対比から阻害能
をめる。H [Physiological activity of the substance of the present invention] ■9 Method for measuring enzyme inhibitory activity of the substance of the present invention Mix the substance of the present invention and an enzyme solution, pre-incubate at 30°C for 5 minutes, and then mix the substrate solution to initiate the reaction. Let it start. 0.5% casein was used as a substrate, and in addition, 5mM calcium chloride, 10mM cysteine, and 50mM
Add mM) Lis-HCl buffer (pH 7,5) and incubate at 30°C.
Let it react for 30 minutes. Then add 6.5%) to the reaction solution.
') The reaction was stopped by adding chloroacetic acid, and the trichloroacetic acid soluble fraction of casein was hydrolyzed by enzymes. Lowy-Folin (Lowy-Folin)
lin ) method, and the inhibitory ability is determined from comparison with a control solution.
結果
本物質0.06μyは1.25μyのパパイン活性を5
0%以上阻害した。同様にカルパインI及びカルパイン
I[[Calcium and Ce1l Funct
lon (W、Y。Results: 0.06μy of this substance increases the papain activity of 1.25μy by 5
Inhibited by 0% or more. Similarly, calpain I and calpain I [[Calcium and Ce1l Funct
lon (W, Y.
Cheung、ed、 ) Vol 、 3 、 Ac
ademic Press p NewYork(19
83):]に対して夫々1μgで25%及び60%の活
性阻害を示した。Cheung, ed.) Vol. 3, Ac.
academic Press New York (19
83):] showed 25% and 60% activity inhibition at 1 μg, respectively.
以上によ−り本発明物質は既存のグロテアーゼ阻害剤で
あるロイペプチンと比較してカルパイン■では低いがノ
4パイン及びカルパイン■に対してよシ強い阻害作用を
有し、特徴的なグロテアーゼ阻害剤である。Based on the above, the substance of the present invention has a stronger inhibitory effect on no4pain and calpain ■ than leupeptin, an existing grotease inhibitor, although it has a lower inhibitory effect on calpain ■, and is a characteristic grotease inhibitor. It is.
■1本発明物質の種子に対する作用
試験法
シャーレに本発明物質の水溶液2dを湿潤させたF紙(
9Qn径)を敷き、オオムギ(単子葉植物)とキュウリ
(双子葉植物)の種子10粒づつをおき、これを30℃
84時間インキュベートし、各各の種子の発芽、発根の
状態を比較する。■1 Test method for the action of the substance of the present invention on seeds A petri dish is moistened with F paper (
9Qn diameter), place 10 seeds each of barley (monocot) and cucumber (dicot), and heat them to 30°C.
Incubate for 84 hours and compare the germination and rooting states of each seed.
対照区としては、水を用いる。Water is used as a control.
本発明物質の水溶液の濃度は、25 、50 。The concentration of the aqueous solution of the substance of the present invention is 25 and 50.
100.500μpゴとする。100.500 μp.
結果
オオムギでは各濃度において対照区との差は認められな
い。Results: In barley, no difference was observed in each concentration compared to the control plot.
キュウリでは、25.50.100μg〜の濃度では根
の生育が悪く、根毛の発生も抑制され、発芽は全く認め
られなかった。また500μfl/mlの濃度では、発
芽、発根とも認められなかった。In cucumbers, at concentrations of 25, 50, 100 μg and above, root growth was poor, the development of root hairs was also suppressed, and no germination was observed. Furthermore, neither germination nor rooting was observed at a concentration of 500 μfl/ml.
以上の結果は、本発明物質の選択的除草剤としての用途
の可能性を示すものである。The above results demonstrate the possibility of using the substance of the present invention as a selective herbicide.
ブドウ糖、ペプトン及び酵母エキスから成る合成培地(
YM培地) 60001d(pH5,8)にSAB −
934株の純培養物を接種し、小型ジャー中で28℃7
2時間培養した後、培養物を遠心し、上清をダイヤイオ
7 HP −20のカラム(140mnX 200Wm
)に吸着させ、とのカラムを水2o、ooo1rLlで
洗浄後、メタノール10,0001mで溶出させた。溶
出物を減圧下に濃縮・乾個させてからこれを水1000
mに溶かし、DEAEセルロース(H型)を充填したカ
ラム(60+a+X100ai)に通した。これを水1
000mA!で洗浄し、先のエルエートと合併して減圧
下に200d容まで濃縮した。濃縮物を塩酸でpH5,
0に調整し、アンパンイトCG−50H+(イオン交換
樹脂)のカラム(60+mnX 1000va )に吸
着させた。Synthetic medium consisting of glucose, peptone and yeast extract (
YM medium) SAB − to 60001d (pH 5, 8)
A pure culture of strain 934 was inoculated and incubated at 28°C in a small jar.
After culturing for 2 hours, the culture was centrifuged and the supernatant was transferred to a Diaio7 HP-20 column (140 mn x 200 Wm
), and the column was washed with 2 ml of water and 1 ml of water, and then eluted with 10,000 ml of methanol. The eluate was concentrated and dried under reduced pressure, and then poured into 1,000 ml of water.
and passed through a column (60+a+X100ai) packed with DEAE cellulose (H type). Add this to 1 part of water
000mA! This was combined with the above elueate and concentrated under reduced pressure to a volume of 200 d. The concentrate was adjusted to pH 5 with hydrochloric acid.
0 and adsorbed onto a column (60+mnX 1000va) of Ampanite CG-50H+ (ion exchange resin).
コ(7)力7ムヲ水1000d及び0.2規定酢酸30
0ml!で洗浄後、−1,0規定ピリジン・酢酸緩衝液
pH5,0゜1001nlで溶出させ、溶出液を減圧・
濃縮し、乾個物を酢酸0.5チを含む50%メタノール
溶液3罰に溶かしてセファデックスLl(−20のカラ
ム(30m+X1850m)に負荷し、酢酸0.5チを
含む50%メタノール溶液10100Oで、溶出分画し
、活性分画を集めた。活性は全100個の分画中筒69
〜第79番目のものに現われた。・活性分画を合併しく
計110コ)、濃縮・乾個させてから水2rILl中に
溶かし、これをセファデックスG−25のカラム(20
s+X470mm)に負荷し、水600dで洗浄後、1
.2%酢酸600dで溶出分画した。活性部分は全10
0個の分画中筒25〜第27番目の分画であった。この
活性分画を濃縮・乾個させることによシ、はぼ純粋な本
発明物質3711417が無色の無定形物質として得ら
れた。(7) Power: 7 mu, water: 1,000 d, and 0.2N acetic acid: 30
0ml! After washing with
After concentrating, the dried solids were dissolved in 50% methanol solution containing 0.5% acetic acid and loaded onto a Sephadex Ll (-20 column (30m + x 1850m). The elution was fractionated, and the active fractions were collected.
~ Appeared in the 79th thing.・Concentrate and dry the active fractions (total of 110 fractions), dissolve in 2ml of water, and apply this to a Sephadex G-25 column (20ml).
s+X470mm), washed with water 600d,
.. It was eluted and fractionated with 2% acetic acid 600d. There are 10 active parts in total.
It was the 25th to 27th fractions in the middle of the 0 fractions. By concentrating and drying this active fraction, almost pure substance 3711417 of the present invention was obtained as a colorless amorphous substance.
特許庁長官 若 杉 和 夫 殿
1.事件の表示
昭和58年特許願第116616号
2、発明の名称
新規なペノチド
3、補正をする者
事件との関係 特許出願人
住所 大阪市北区堂島浜2丁目1番40号名称 (19
0)サントリー株式会社
代表者佐治敬三
4、代理人
住所 東京都港区元赤坂1丁目2番3号サントリー株式
会社特許室
(電話 470−1131 )
6、補正の内容
(1) 明細書の「特許請求の範囲」を別紙のとおり改
める。Kazuo Wakasugi, Commissioner of the Patent Office1. Display of the case 1982 Patent Application No. 116616 2, Name of the invention New penotide 3, Relationship with the person making the amendment Patent applicant address 2-1-40 Dojimahama, Kita-ku, Osaka Name (19)
0) Suntory Ltd. Representative Keizo Saji 4, Agent Address Suntory Ltd. Patent Office, 1-2-3 Motoakasaka, Minato-ku, Tokyo (Telephone: 470-1131) 6. Contents of Amendment (1) "Patent" in the specification "Scope of Claims" has been revised as shown in the attached sheet.
(2)明細書の第1頁下2行目:「残有を示す。」とあ
るのを「残基を示す。」に改める。(2) Page 1, bottom 2nd line of the specification: "Indicates residual presence." is changed to "Indicates residue."
(3)明細書の第7頁、13行行目:0ペゾトン水(1
,0%硝酸塩含有)」とあるのを「のペゾトン水(1,
0%硝酸塩含有)(28℃培養)」に改めるう
(4)明細書の第9頁、15〜16行目:「硝酸塩の還
元反応は全て陽性で」とあるのを「硝酸塩の還元反応は
陽性で」に改める。(3) Page 7, line 13 of the specification: 0 pezoton water (1
, 0% nitrate content)" is replaced with "pezoton water (1, 0% nitrate content)"
(4) Page 9, lines 15-16 of the specification: ``All nitrate reduction reactions are positive'' has been changed to ``Nitrate reduction reactions are positive.'' It was changed to ``Positive.''
(5)明細書の第11頁、表中、発育の色の項目の「黄
色〜淡黄色」とあるのを「黄色〜淡灰色」と改める。(5) In the table on page 11 of the specification, the term "yellow to light yellow" in the color of growth section has been changed to "yellow to light gray."
(6) 明細書の第12頁、14行行目:コーンステイ
ブリカー」とあるのを「コーンステイブリカー」に改め
る。(6) Page 12, line 14 of the specification: "Corn Stable Liquor" shall be changed to "Corn Stable Liquor."
(7) 明細書の第13頁、18行目:「培養物からの
」とあるのを「培養液からの」と改める。(7) Page 13, line 18 of the specification: "From culture" is changed to "from culture solution."
(8)明細書の第13頁、20行目〜明細書の第14頁
、2行目:「即ち、例えば硫酸アンモニウム等の沈澱剤
の添加による沈澱、n−ブタノールなど」とあるのを「
即ち、例えば、n−ブタノールなど」と改める。(8) Page 13, line 20 of the specification to page 14, line 2 of the specification: ``i.e., precipitation by addition of a precipitating agent such as ammonium sulfate, n-butanol, etc.'' is replaced with ``
That is, for example, n-butanol, etc."
(9)明細書の第15頁、下から10行目:rFn−M
S : m/Z 504 (M+) Jとあるのをl’
−FD−MS:mHz 505 (M+1 )+Jと改
める。(9) Page 15 of the specification, line 10 from the bottom: rFn-M
S: m/Z 504 (M+) J and l'
-FD-MS: mHz 505 (M+1)+J.
αG 明細書の第16頁、19行〜20行目:「坂口反
応及びトレンズテストに陽性、ニンヒドリン及ヒ2,4
−ジニトロフェニル・ヒドラジンには」とあるのを「坂
口反応、パクリ反応及びトレンズテストに陽性、ニンヒ
ドリンには」と改める。αG Specification, page 16, lines 19-20: “Positive for Sakaguchi reaction and Tollens test, ninhydrin and 2,4
- For dinitrophenyl hydrazine" has been changed to "Positive for Sakaguchi reaction, plagiarism reaction, and Tollens test, for ninhydrin."
0■ 明細書の第21頁、2行目:[ブドウ糖、ペプト
ン及び酵母エキスから」とあるのを「プドーウ糖、ペプ
トン、マルトエキス及び酵母エキスから」に改める。0 ■ Page 21, line 2 of the specification: [From glucose, peptone, and yeast extract] is changed to "From pudu sugar, peptone, malt extract, and yeast extract."
(ロ) 明細書の第21頁、10行目: r DEAE
セルロース(H型)を」とあるのをr DEAEセルロ
ース(OH型)を」と改める。(b) Page 21, line 10 of the specification: r DEAE
``Cellulose (H type)'' has been changed to ``r DEAE cellulose (OH type)''.
0埠 明細書の第21頁、14行〜15行目二「アンパ
ライトCG−50H+(イオン交換樹脂)のカラム(6
0s+X1000閣)に」とあるのを「アンバーライト
CG−’50(H型)のカラム(60間×100瓢)に
」に改める。Page 21 of the specification, lines 14 to 15, 2 “Amparite CG-50H+ (ion exchange resin) column (6
0s +
a< 明細書の第21頁、18行目:r10omlで溶
出させ、」とあるのをrlooomlで溶出させ、」と
改める。a< Page 21, line 18 of the specification: ``Elute with r10oml,'' has been changed to ``Elute with rlooooml,''.
7、添付書類の目録
(1)別 紙 1通
〔別紙〕
「2、特許請求の範囲
構造式
(但し、上式中のl5ovalery+はインバレリル
基を表わし、Tyr及びVal はそれぞれチロシン及
びバリンの残基を示す。)で表わされる新規なペプチド
。」7. List of attached documents (1) 1 attached sheet [Attachment] 2. Claims Structural Formula (In the above formula, l5ovalery+ represents an invaleryl group, and Tyr and Val are tyrosine and valine residues, respectively. A novel peptide represented by
Claims (1)
リル基を表わし、Tyr及びValはそれぞれチロシン
及びバリンの残有を示す。)で表わされる新規なペプチ
ド。[Scope of Claims] A novel peptide represented by the structural formula (in the above formula, l5ovaleryl Id represents an invaleryl group, and Tyr and Val represent residual tyrosine and valine, respectively).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58116616A JPS6028990A (en) | 1983-06-28 | 1983-06-28 | Novel peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58116616A JPS6028990A (en) | 1983-06-28 | 1983-06-28 | Novel peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6028990A true JPS6028990A (en) | 1985-02-14 |
Family
ID=14691588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58116616A Pending JPS6028990A (en) | 1983-06-28 | 1983-06-28 | Novel peptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6028990A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040743A3 (en) * | 1995-06-07 | 1997-01-23 | Cor Therapeutics Inc | Inhibitors of factor xa |
-
1983
- 1983-06-28 JP JP58116616A patent/JPS6028990A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996040743A3 (en) * | 1995-06-07 | 1997-01-23 | Cor Therapeutics Inc | Inhibitors of factor xa |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4226941A (en) | Process for the optical resolution of d,l-2-amino-4-methylphosphinobutyric acid | |
JPS6254433B2 (en) | ||
JPS6254320B2 (en) | ||
US4014860A (en) | Plasminostreptin (enzyme inhibitor) and method for producing it from streptomyces | |
JPS6028990A (en) | Novel peptide | |
JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
US3692777A (en) | 5h-pyrrolo {8 2,1-c{9 {8 1,4{9 {0 benzodiazepin-5-ones | |
CA1131146A (en) | Amylase inhibitors | |
CH393638A (en) | Process for preparing a new antibiotic | |
JPS6210048A (en) | Novel physiologically active substance mh435 | |
JPH0144198B2 (en) | ||
JPS5928493A (en) | Preparation of alkyl ester of aspartylphenylalanine | |
JPH05310766A (en) | New antibiotic substance mi481-42f4-a and its produciton | |
JP2990628B2 (en) | New plant growth regulating substance aji-302 and its production | |
JP3448334B2 (en) | Piperastatin A, a novel physiologically active substance and a method for producing the same | |
JPH0283351A (en) | Novel alpha-glucosidase-inhibiting substance benanomicin c and production thereof | |
JPH0474163A (en) | New physiologically active substance mbp049-13 and production thereof | |
JPS58170482A (en) | Novel antibiotic 662-a substance and 662-a' substance and their preparation | |
JPS62186787A (en) | Novel microorganism | |
JPH05331181A (en) | Farnesyltransferase-inhibitory substance oh-4652 and its production | |
JPS62132897A (en) | Physiologically active substance k-13 and production thereof | |
JPH04198193A (en) | New enzyme inhibitor benartin and its production | |
JPH08176157A (en) | New physiologically active substance epostatin, its production and use | |
JPS62207296A (en) | Novel compound wk-142 and production thereof | |
JPS61115100A (en) | Dc-79 and preparation thereof |